SCHEMBL6948828

SCHEMBL6948828

Cc1nccn1CCCC(=O)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
POLB P06746 1/20 0.51
KMT2A Q03164 1/20 0.51
TBXAS1 P24557 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
LMNA P02545 1/20 0.49
MAPT P10636 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
KDM4E B2RXH2 1/20 0.48
HTT P42858 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C19 P33261 1/20 0.48
P2RX7 Q99572 1/20 0.47
NOS1 P29475 1/20 0.47
ESR1 P03372 1/20 0.47
CTNNB1 P35222 1/20 0.46
WNT3A P56704 1/20 0.46
ALPL P05186 2/20 0.46
ALPG P10696 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6947633 0.91 ESR1 (0.52) ALDH1A1POLBKMT2ATBXAS1NOS1
SCHEMBL11144610 0.89 MMP1 (0.46) ALDH1A1POLBKMT2ALMNASMN1; SMN2
SCHEMBL6950320 0.86 NPC1 (0.53) ALDH1A1POLBKMT2ALMNASMN1; SMN2
SCHEMBL7080414 0.83 HDAC1 (0.47) ALDH1A1POLBKMT2ASMN1; SMN2KDM4E
SCHEMBL4926204 0.82 NOS1 (0.66) POLBKMT2ATDP1SMN1; SMN2KDM4E
SCHEMBL26488900 0.82 ALDH1A1 (0.61) ALDH1A1POLBKMT2ASMN1; SMN2KDM4E
SCHEMBL11147242 0.80 MMP1 (0.48) ALDH1A1POLBKMT2AL3MBTL1LMNA
SCHEMBL10856186 0.80 CA12 (0.51) ALDH1A1POLBKMT2ATBXAS1LMNA
Benzil SCHEMBL27438154 0.80 ALDH1A1 (0.59) ALDH1A1POLBKMT2ALMNASMN1; SMN2
SCHEMBL6943126 0.77 ALDH1A1 (0.50) ALDH1A1POLBKMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709378-B1 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds AVENTIS PHARMA INC (US) 2003-03-19 EP disclosed
US-5770740-A TREATING DEPRESSION AND OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1998-06-23 US disclosed
US-5696142-A TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-12-09 US disclosed
US-5686447-A ANTIDEPRESSANTS, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-11-11 US disclosed
US-5686483-A TREATING DEPRESSION AND OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-11-11 US disclosed
US-5686446-A ANTIDEPRESSANTS, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-11-11 US disclosed
US-5684021-A Aminoalkyloximes for treating depression and affective disorders HOECHST MARION ROUSSEL, INC. (US) 1997-11-04 US disclosed
US-5665756-A Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders HOECHST MARION ROUSSEL, INC. (US) 1997-09-09 US disclosed
US-5648367-A ANTIDEPRESANTS, OBSESSIVE-COMPULSIVE DISORDER HOECHST MARION ROUSSEL, INC. (US) 1997-07-15 US disclosed
EP-0709378-A2 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1996-05-01 EP disclosed